Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$657M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$587M |
| 4 |
AstraZeneca
AZN
|
+$319M |
| 5 |
Snowflake
SNOW
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GAN
2501
DELISTED
GAN Ltd
GAN
| $371K | ﹤0.01% |
24,970
+6,457
| +35% | +$103K |
|
2502
Hyliion Holdings
HYLN
$690M
| $371K | ﹤0.01% |
44,203
+18,507
| +72% | +$171K |
|
2503
Douglas Dynamics
PLOW
$1.02B
| $371K | ﹤0.01% |
10,247
+4,484
| +78% | +$173K |
|
2504
Hydrofarm Holdings
HYFM
$7.62M
| $370K | ﹤0.01% |
977
+807
| +475% | +$392K |
|
2505
Liberty Energy
LBRT
$3.25B
| $370K | ﹤0.01% |
30,423
+18,249
| +150% | +$202K |
|
|
CCF
2506
DELISTED
Chase Corporation
CCF
| $368K | ﹤0.01% |
3,597
+1,482
| +70% | +$165K |
|
2507
Nuvation Bio
NUVB
$2.32B
| $365K | ﹤0.01% |
36,618
+26,655
| +268% | +$242K |
|
2508
Protagonist Therapeutics
PTGX
$9.44B
| $365K | ﹤0.01% |
20,632
+8,071
| +64% | +$344K |
|
2509
Construction Partners
ROAD
$6.77B
| $365K | ﹤0.01% |
10,949
+6,240
| +133% | +$205K |
|
2510
Ultrapar
UGP
$6.54B
| $365K | ﹤0.01% |
135,500
| – | – |
|
|
WOW
2511
DELISTED
WideOpenWest
WOW
| $365K | ﹤0.01% |
18,561
+10,238
| +123% | +$215K |
|
2512
Ranpak Holdings
PACK
$473M
| $364K | ﹤0.01% |
13,562
+9,141
| +207% | +$257K |
|
|
DESP
2513
DELISTED
Despegar.com
DESP
| $363K | ﹤0.01% |
30,228
+7,628
| +34% | +$93.9K |
|
|
LBAI
2514
DELISTED
Lakeland Bancorp Inc
LBAI
| $362K | ﹤0.01% |
20,563
+9,459
| +85% | +$157K |
|
2515
Kura Oncology
KURA
$850M
| $360K | ﹤0.01% |
19,242
+11,123
| +137% | +$210K |
|
2516
United States Lime & Minerals
USLM
$3.44B
| $358K | ﹤0.01% |
14,835
+2,530
| +21% | +$70.4K |
|
2517
Gogo Inc
GOGO
$492M
| $356K | ﹤0.01% |
20,566
+9,319
| +83% | +$113K |
|
2518
Univest Financial
UVSP
$1.18B
| $355K | ﹤0.01% |
12,957
+5,569
| +75% | +$149K |
|
|
AXIA.PR
2519
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
| $354K | ﹤0.01% |
62,510
| – | – |
|
|
ETWO
2520
DELISTED
E2open Parent Holdings
ETWO
| $351K | ﹤0.01% |
31,012
+24,421
| +371% | +$274K |
|
|
TARO
2521
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $351K | ﹤0.01% |
5,515
+50
| +0.9% | +$3.46K |
|
2522
Cars.com
CARS
$660M
| $349K | ﹤0.01% |
27,596
-26,410
| -49% | -$334K |
|
|
AVID
2523
DELISTED
Avid Technology Inc
AVID
| $347K | ﹤0.01% |
11,995
+6,352
| +113% | +$196K |
|
2524
Applied Optoelectronics
AAOI
$11.5B
| $346K | ﹤0.01% |
48,136
| – | – |
|
2525
Horizon Bancorp
HBNC
$1.04B
| $344K | ﹤0.01% |
18,929
+10,783
| +132% | +$186K |
|
Similar funds
Legal & General Group's Q3 2021 Portfolio in Review
As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.
- Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
- Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
- Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
- Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
- Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
- Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
- Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.
Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.